跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CURAM POWDER FOR ORAL SUSPENSION 312.5 mg/5 ml - HSA Drug Approval Details
Approvals
/
HSA
/
CURAM POWDER FOR ORAL SUSPENSION 312.5 mg/5 ml
Approved
THERAPEUTIC
CURAM POWDER FOR ORAL SUSPENSION 312.5 mg/5 ml
SANDOZ GMBH
🇸🇬 Health Sciences Authority
Approval Date
Jan 6, 1999
Approval ID
4ec0ee698f278edd
Company
SANDOZ GMBH
Type
Therapeutic
Approval Details
Approval Id
4ec0ee698f278edd
Drug Name
CURAM POWDER FOR ORAL SUSPENSION 312.5 mg/5 ml
Product Name
CURAM POWDER FOR ORAL SUSPENSION 312.5 mg/5 ml
Approval Number
SIN10604P
Approval Date
1999-01-06
Registrant
NOVARTIS (SINGAPORE) PTE LTD
Licence Holder
SANDOZ SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
POWDER, FOR SUSPENSION
Route Of Administration
ORAL
Atc Code
J01CR02
Atc Item Name
amoxicillin and beta-lactamase inhibitor
Pharma Manufacturer Name
SANDOZ SINGAPORE PTE. LTD.
Company Detail Path
/organization/sandoz-singapore-pte-ltd
Active Ingredients
Amoxicillin Trihydrate 287mg/5ml EQV to Amoxicillin
250mg/5ml
Potassium Clavulanate 84mg/5ml EQV to Clavulanic Acid
62.5 mg/5 ml
Amoxicillin Trihydrate 287mg/5ml EQV to Amoxicillin
250mg/5ml
Potassium Clavulanate 84mg/5ml EQV to Clavulanic Acid
62.5 mg/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 6, 1999
Approval ID
4ec0ee698f278edd
Type
Therapeutic
Back to HSA Approvals
